NCI PATTERNS OF CARE (POC)/QUALITY OF CARE STUDY: DIAGNOSIS YEAR 2019 (URINARY BLADDER CANCER AND KIDNEY CANCER)

NCI 护理模式 (POC)/护理质量研究：2019 年诊断年（膀胱癌和肾癌）

• 批准号: 10472103
• 负责人: KEVIN WARD
• 金额: $ 13.83万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-05 至 2022-04-04
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10472103
• 关键词: Adjuvant Therapy; Age; Beds; Biological Markers; Caring; Characteristics; Communities; Diagnosis; Diagnostic tests; Documentation; Educational process of instructing; Ethnic Origin; Geographic Locations; Hospitals; Immunoglobulin Variable Region; Immunotherapy; Incidence; Inpatients; Insurance Coverage; Malignant neoplasm of urinary bladder; Medical Records; Operative Surgical Procedures; Outpatients; Patients; Pattern; Patterns of Care; Pharmaceutical Preparations; Physicians; Physicians' Offices; Quality of Care; Race; Radiation therapy; Records; Renal carcinoma; Systemic Therapy; Testing; Time; cancer recurrence; cancer therapy; chemotherapy; comorbidity; hormone therapy; multidisciplinary; sex; targeted treatment

The primary objectives of the Fiscal Year 2021 NCI POC Study are to: 1) describe the use of recommended biomarker tests which shall be verified with the treating physician/physician office staff or with a unified medical record (record with all inpatient and outpatient records in a single file) and 2) describe the use of targeted therapy which shall be verified with the treating physician/physician office staff or with a unified medical record (record with all inpatient and outpatient records in a single file). Other objectives are to: 3) describe the use of adjuvant therapy, which shall be verified with the treating physician/physician office staff or with a unified medical record (record with all inpatient and outpatient records in a single file); 4) characterize the practice patterns in different communities; 5) compare the patterns of treatment (surgery, radiation therapy, systemic therapy (chemotherapy, immunotherapy, hormonal therapy, targeted therapy), and other adjuvant therapy) over time and by age, sex, race/ethnicity, and insurance status; 6) describe comorbidities and the effect of co-morbid conditions on treatment; 7) describe treatment by hospital characteristics (i.e., for profit vs. not for profit, teaching vs. non-teaching, bed size, etc.); 8) describe the use of diagnostic tests and compare their use by demographic variables and geographic region; 9) describe the medical record documentation of multidisciplinary care and patient navigation; 10) assess the incidence of cancer recurrence; and 11) collect information on changes in cancer treatment patterns due to medication shortages.

2021财年NCI POC研究的主要目标是：1）描述使用建议的生物标志物测试的使用，应通过治疗的医师/医师办公室工作人员或具有统一的病历来验证，并具有统一的医疗记录（记录所有患者和门诊记录和单个文件中的所有患者记录，以及与目标疗法的使用，并描述具有统一的医疗疗法或与物理学的使用，或者是一定程度的医疗疗法，或者是一定的，或者是一定程度的医疗疗法，或者是一定的。单个文件中的所有住院和门诊记录）。其他目的是：3）描述使用辅助治疗的使用，该治疗疗法应与治疗医师/医师办公室工作人员或统一的病历一起验证（记录单个文件中所有住院和门诊记录的记录）； 4）表征不同社区的实践模式； 5）随着时间和年龄，性别，性别，种族/族裔和保险状态，比较治疗方式（手术，放射疗法，全身治疗，免疫疗法，荷尔蒙治疗，靶向治疗）和其他辅助治疗的模式； 6）描述合并症和合并症条件对治疗的影响； 7）描述通过医院特征来描述治疗（即，为了利润而不是为了利润，教学与非教学，床尺寸等）； 8）描述使用诊断测试的使用，并比较其通过人口统计学变量和地理区域的使用； 9）描述了多学科护理和患者导航的病历文件； 10）评估癌症复发的发生率； 11）收集有关药物短缺导致癌症治疗模式变化的信息。